Top Markets
Coin of the day
AcelRx Pharmaceuticals, Inc. AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc.

ACRX
Pozycja w akcjach #31915
AcelRx Pharmaceuticals, Inc. is a specialized biopharmaceutical firm primarily... AcelRx Pharmaceuticals, Inc. is a specialized biopharmaceutical firm primarily dedicated to advancing and bringing to market medical solutions for managing acute pain. The company's key commercial products include DSUVIA and DZUVEO, which are 30 microgram sufentanil tablets administered under the tongue, intended for treating significant short-term pain. AcelRx also develops ZALVISO, a pre-programmed, patient-managed analgesia system that enables hospital patients experiencing moderate-to-severe acute pain to self-administer sufentanil sublingual tablets for their pain relief. In its development pipeline, AcelRx is progressing ARX-02, which is currently in Phase 2 clinical trials, targeting sudden, intense cancer-related pain in individuals who are tolerant to opioid medications. Another candidate, 4ARX-03, is being investigated for its utility in providing mild sedation and pain relief during various medical procedures that might cause discomfort. Beyond acute pain, AcelRx's investigational portfolio features Niyad, a regional anticoagulant designed for use in external blood circulation systems. Furthermore, LTX-608, a nafamostat formulation for direct intravenous infusion, is being explored as an experimental treatment for a range of conditions, including COVID, severe lung injury (acute respiratory distress syndrome), widespread blood clotting (disseminated intravascular coagulation), and acute pancreatitis. The company was founded in 2005 and initially operated under the name SuRx, Inc., before officially rebranding as AcelRx Pharmaceuticals, Inc. in August 2006. It is headquartered in Hayward, California.
Cena akcji
$0.922
Ostatnia synchronizacja: 2024-02-05
Kapitalizacja rynkowa
$11.68M
Zmiana (1 dzień)
-1.91%
Zmiana (1 rok)
0.00%
Kraj
US
Handel AcelRx Pharmaceuticals, Inc. (ACRX)

Kategoria

Historia ceny akcji dla AcelRx Pharmaceuticals, Inc. (ACRX)
Najwyższa cena zamknięcia: $0.97 dnia 2024-02-01

Najniższa cena zamknięcia: $79.56 dnia 2011-02-01
Historia cen akcji firmy AcelRx Pharmaceuticals, Inc. od 2011 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 26.40%
2023 -64.67%
2022 -80.39%
2021 -58.51%
2020 -36.98%
2019 -21.96%
2018 30.20%
2017 -27.31%
2016 -34.24%
2015 -32.90%
2014 -31.99%
2013 150.50%
2012 50.28%
2011 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$161.38 24.86%
DE
$37.20 22.61%
JP
$217.65 31.41%
CH
$20.74 10.88%
IN